March is Colorectal Cancer Month. It is recommended that individuals age 50 and older receive routine screenings to increase their chances of survival. Lake Medical Imaging offers state-of-the-art diagnostic tools and minimally invasive Virtual Colonoscopy to detect polyps and cancerous cells at their most treatable stages.
Category Archives: Lake Medical Imaging Center News
Peripheral artery disease, or P.A.D., is a condition whereby hard and soft plaque (fat and cholesterol), calcium, clots and fibrous tissue accumulate in the arteries and become clogged, causing decreased blood flow to a specific area.
Continuing our acknowledgement of American Heart Month, this article sheds light on one of the many non-invasive tests offered by Lake Medical Imaging.
February is American Heart Month. Lake Medical Imaging offers a wide range of non-invasive tests to detect heart and vascular disease to help your physician plan the best course of treatment.
A high-profile lawsuit regarding the safety of gadolinium MRI contrast filed by martial arts actor Chuck Norris and his wife against contrast developer Bracco Imaging has been voluntarily dismissed, according to the company.
One prominent Chicago pediatric hospital is launching an “Abandon the Shield” campaign to begin moving away from using lead protection for patients during imaging exams this spring. Another a few miles away is mulling the same, despite the initial “shock” clinicians felt when presented with the idea.
Breast cancer remains the most commonly diagnosed cancer worldwide. Obesity is a risk factor for postmenopausal breast cancer, particularly when excess…
By Abraham Kim, AuntoMinnie.com Staff Writer November 13, 2019 — Researchers from Colorado have proposed expanding the diagnostic criteria for chronic obstructive pulmonary disorder (COPD) to consider CT data along with a patient’s symptoms, environmental exposure, and spirometry results in […]
Pinpointing Prostate Cancer Lake Medical Imaging’s PET (Positron Emission Tomography) scan utilizes Axumin™, an imaging agent that makes it easier to pinpoint recurring prostate cancer in patients with an elevated PSA who have been previously treated. In the past, conventional […]